One small study did analyze anti-PAD4 antibodies titers, but not the PAD3 cross-reactive subset, longitudinally in a predominantly Caucasian population with a mean RA disease duration of 11.5 years [13]. Here, PADI4 is linked to rheumatoid arthritis.